High-Level Commercial Due Diligence in Digital Pathology
Financial Services
13
4
Due Diligence
Objective
An early-stage venture firm requested a high-level commercial due diligence of a potential investment
Our Approach
Primary Research
- Conducted 13 interviews with experts from biopharma, clinical settings, and industry to assess the company's value proposition
Secondary Research
- Assessed the competitive landscape and clinical workflows in specific indications to understand how the company fits in
Outcome
DeciBio presented a deliverable detailing the digital pathology landscape, the company's niche in the space, and potential go-to-market plans and considerations.
Quantitative Analysis
- Company revenue estimation using comparable competitors as benchmarks
Qualitative Analysis
- Potential clinical pricing / commercialization models
- Timeline to clinic
- Clinical go-to-market considerations by geography and stakeholder type
Related Client Results
![](https://cdn.prod.website-files.com/63efba2f7355c4b402e8c186/63faf6b70e70bd5f2f504b55_10.png)
Early-Stage Cancer Biomarker Testing and Treatment Landscape Assessment
Competitive Analysis
Voice-of-Customer Research
![](https://cdn.prod.website-files.com/63efba2f7355c4b402e8c186/63faf72f0e9534164db18e51_20.png)
Carrier Screening Landscape Assessment
Voice-of-Customer Research
![](https://cdn.prod.website-files.com/63efba2f7355c4b402e8c186/63faf7d68bb369282a139391_16_blue.png)
Low-Throughput Molecular Diagnostic Testing Landscape Assessment
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation